The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.
Liu
P
P
Heart & Stroke/RL Centre of Excellence, Toronto General Hospital, Ontario, Canada. peter.liu@utoronto.ca
Arnold
J M
JM
Belenkie
I
I
Demers
C
C
Dorian
P
P
Gianetti
N
N
Haddad
H
H
Howlett
J
J
Ignazewski
A
A
Jong
P
P
McKelvie
R
R
Moe
G
G
Parker
J D
JD
Rao
V
V
Rouleau
J L
JL
Teo
K
K
Tsuyuki
R
R
White
M
M
Huckel
V
V
Issac
D
D
Johnstone
D
D
LeBlanc
M-H
MH
Lee
H
H
Newton
G
G
Niznick
J
J
Ross
H
H
Roth
S
S
Roy
D
D
Smith
S
S
Sussex
B
B
Yusuf
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000097:blood; D002170:Canada; D002309:Cardiology; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D020097:Natriuretic Peptide, Brain; D012955:Societies, Medical
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor